Literature DB >> 7751623

MHC class II compartments and the kinetics of antigen presentation in activated mouse spleen dendritic cells.

M J Kleijmeer1, M A Ossevoort, C J van Veen, J J van Hellemond, J J Neefjes, W M Kast, C J Melief, H J Geuze.   

Abstract

MHC class II (MHC-II) molecules bind fragments of exogenous Ags in an intracellular endocytotic compartment. In view of divergent data on the MHC-II distribution in different cell lines, it was of interest to localize MHC-II molecules in a natural and the most potent APC type, the dendritic cell (DC). By using immunogold labeling of ultrathin cryosections of cultured mouse spleen DC, we found that MHC-II molecules were present abundantly at the plasma membrane and in intracellular compartments containing internal membrane vesicles and/or membrane sheets. The majority of these compartments was situated late in the endocytotic route, as demonstrated by the late appearance (after a lag of 30 min) of internalized exogenous tracer. These compartments contained the lysosomal enzymes cathepsin D and beta-hexosaminidase, but lacked the late endosomal marker cation-dependent mannose-6-phosphate receptor. We conclude that most of the intracellular MHC-II molecules in cultured spleen DC reside in a compartment with (pre)lysosomal characteristics, resembling the so-called MHC-II-enriched compartments (MIIC), originally described in B cells. We also investigated whether the presence of MHC-II molecules in endocytotic compartments was related to the kinetics of Ag processing and presentation by these cells. Pulse-chase endocytosis experiments with hen egg lysozyme (HEL) as a model Ag showed that activated spleen DC were able to efficiently process and present this Ag to an HEL-specific T hybridoma cell line. However, presentation started only after a lag of 2 h and was maximal after 6 h. The difference in time between the arrival of Ag in proteolytic endocytotic compartments, in particular MIIC, and effective Ag presentation is discussed in the context of DC maturation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7751623

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  Targeting vaccines to dendritic cells.

Authors:  Camilla Foged; Anne Sundblad; Lars Hovgaard
Journal:  Pharm Res       Date:  2002-03       Impact factor: 4.200

Review 2.  The ins and outs of MHC class II-mediated antigen processing and presentation.

Authors:  Paul A Roche; Kazuyuki Furuta
Journal:  Nat Rev Immunol       Date:  2015-02-27       Impact factor: 53.106

3.  Fused late endocytic compartments and immunostimulatory capacity of dendritic-tumor cell hybridomas.

Authors:  Mateja Gabrijel; Martina Bergant; Marko Kreft; Matjaz Jeras; Robert Zorec
Journal:  J Membr Biol       Date:  2009-05-06       Impact factor: 1.843

4.  Major histocompatibility complex class II-peptide complexes internalize using a clathrin- and dynamin-independent endocytosis pathway.

Authors:  Even Walseng; Oddmund Bakke; Paul A Roche
Journal:  J Biol Chem       Date:  2008-03-31       Impact factor: 5.157

5.  Purification of intracellular compartments involved in antigen processing: a new method based on magnetic sorting.

Authors:  L A Perrin-Cocon; P N Marche; C L Villiers
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

6.  Accumulation of major histocompatibility complex class II molecules in mast cell secretory granules and their release upon degranulation.

Authors:  G Raposo; D Tenza; S Mecheri; R Peronet; C Bonnerot; C Desaymard
Journal:  Mol Biol Cell       Date:  1997-12       Impact factor: 4.138

7.  Dendritic cell maturation and antigen presentation in the absence of invariant chain.

Authors:  P Rovere; V S Zimmermann; F Forquet; D Demandolx; J Trucy; P Ricciardi-Castagnoli; J Davoust
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-03       Impact factor: 11.205

Review 8.  The immunobiology of ubiquitin-dependent B cell receptor functions.

Authors:  James R Drake
Journal:  Mol Immunol       Date:  2018-06-26       Impact factor: 4.407

9.  Introduction of the CIITA gene into tumor cells produces exosomes with enhanced anti-tumor effects.

Authors:  Yeong Shin Lee; Soo Hyun Kim; Jung Ah Cho; Chul Woo Kim
Journal:  Exp Mol Med       Date:  2011-05-31       Impact factor: 8.718

Review 10.  Presentation of phagocytosed antigens by MHC class I and II.

Authors:  Adriana R Mantegazza; Joao G Magalhaes; Sebastian Amigorena; Michael S Marks
Journal:  Traffic       Date:  2012-11-29       Impact factor: 6.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.